MING-LUNG YU
Kaohsiung Medical University
H-index: 67
Asia-Taiwan
Top articles of MING-LUNG YU
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Results from a phase 2 study of triplet blockade of the IL-27, PD-(L) 1, and VEGF pathways with casdozokitug (casdozo, SRF388) in combination with atezolizumab (atezo) and … | Daneng Li Kun-Ming Rau Ming-Lung Yu Hong Jae Chon Hsueh-Chou Lai | 2024/1/20 | |
Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma | Journal of Translational Medicine | Ciniso Sylvester Shabangu Wen-Hsiu Su Chia-Yang Li Ming-Lung Yu Chia-Yen Dai | 2024/3/12 |
Hepatitis C virus micro‐elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide | Chi‐Ming Tai Ming‐Lung Yu | 2023/11/27 | |
Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer | Clinical and Molecular Hepatology | Pin-Nan Cheng Ming-Lung Yu | 2024/4 |
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC | Clinical Gastroenterology and Hepatology | Mei-Hsuan Lee Yi-Ting Chen Yu-Han Huang Sheng-Nan Lu Tsai-Hsuan Yang | 2024/2/15 |
Patient‐centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in Taiwan | The Kaohsiung Journal of Medical Sciences | Chung‐Feng Huang Tyng‐Yuan Jang Shun‐Chieh Yu Shin‐Chung Huang Shao‐Lun Ho | 2024/1 |
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease | The Kaohsiung Journal of Medical Sciences | Tyng‐Yuan Jang Chi‐Chang Ho Po‐Cheng Liang Chih‐Da Wu Yu‐Ju Wei | 2024/3 |
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan | Infectious Diseases and Therapy | Chun-Chi Yang Chung-Feng Huang Te-Sheng Chang Ching-Chu Lo Chao-Hung Hung | 2024/4/28 |
The efficacy of multi‐disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients | The Kaohsiung Journal of Medical Sciences | Ming‐Lun Yeh Chia‐Yen Dai Chung‐Feng Huang Shiu‐Feng Huang Pei‐Chien Tsai | 2024/4/16 |
Pretreatment gamma‐glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs | The Kaohsiung Journal of Medical Sciences | Tyng‐Yuan Jang Po‐Cheng Liang Dae Won Jun Jang Han Jung Hidenori Toyoda | 2024/2 |
Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature | Journal of Hepatology | Amedeo Lonardo Fernando Bril Stephen H Caldwell Mohammed Eslam Jian-Gao Fan | 2024/2/8 |
Cardiovascular risk of TDF or TAF in patients with chronic hepatitis B: more questions than an answer | Clinical and Molecular Hepatology | Pin-Nan Cheng Ming-Lung Yu | 2024/2/19 |
Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study | Alimentary Pharmacology & Therapeutics | Eiichi Ogawa Dae Won Jun Hidenori Toyoda Yao‐Chun Hsu Eileen L Yoon | 2024/1 |
Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response | Alimentary Pharmacology & Therapeutics | Jung Eun Park Vy H Nguyen Pei‐Chien Tsai Hidenori Toyoda Jennifer Leong | 2024/1/3 |
Unmet needs in the post-DAA era: the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication | Chung-Feng Huang Manar Hijaze Awad Meital Gal-Tanamy Ming-Lung Yu | 2024/4/26 | |
Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis | The Kaohsiung Journal of Medical Sciences | Chung‐Feng Huang Po‐Cheng Liang Chih‐Wen Wang Tyng‐Yuan Jang Po‐Yao Hsu | 2024/1/17 |
Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study | Hepatology International | Chin-I Shih Kuan-Ta Wu Meng-Hsuan Hsieh Jeng-Fu Yang Yi-Yu Chen | 2024/2 |
Correspondence on Letter regarding “Toward hepatitis C virus elimination using artificial intelligence” | Clinical and Molecular Hepatology | Ming-Ying Lu Ming-Lung Yu | 2024/3/5 |
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study | Journal of Gastroenterology and Hepatology | Tyng‐Yuan Jang Po‐Cheng Liang Dae Won Jun Jang Han Jung Hidenori Toyoda | 2024 |
Sex differences in treatment response to nucleos (t) ide therapy in chronic hepatitis B: a multicenter longitudinal study | Clinical Gastroenterology and Hepatology | Angela Chau Ming-Lun Yeh Pei-Chien Tsai Daniel Q Huang Sung Eun Kim | 2023/9/19 |
Co-Authors
